| scholarly article | Q13442814 |
| P50 | author | Eden R Martin | Q67215561 |
| Gary W Beecham | Q124706380 | ||
| Jeffery M. Vance | Q30362072 | ||
| Stephan Züchner | Q30500867 | ||
| Daniel D Kinnamon | Q46343676 | ||
| Güney Bademci | Q46520424 | ||
| P2093 | author name string | William K Scott | |
| Arpit Mehta | |||
| Liyong Wang | |||
| Vanessa Inchausti | |||
| Karen Nuytemans | |||
| Amy Dressen | |||
| P2860 | cites work | A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death | Q24291746 |
| Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 | ||
| Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 | ||
| Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism | Q24321359 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| Identification of VPS35 mutations replicated in French families with Parkinson disease | Q59697029 | ||
| Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease | Q24531223 | ||
| Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease | Q24596763 | ||
| A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease | Q24633417 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase | Q28116395 | ||
| Translation initiator EIF4G1 mutations in familial Parkinson disease | Q28247679 | ||
| Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease | Q28257086 | ||
| Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease | Q28292932 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
| Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants | Q29615627 | ||
| Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin | Q29615684 | ||
| ESEfinder: A web resource to identify exonic splicing enhancers | Q29616126 | ||
| Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach | Q33833978 | ||
| Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease | Q33858726 | ||
| Rare-variant association testing for sequencing data with the sequence kernel association test | Q33954046 | ||
| Reconsidering association testing methods using single-variant test statistics as alternatives to pooling tests for sequence data with rare variants | Q34169930 | ||
| The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization | Q34836156 | ||
| VPS35 mutations in Parkinson disease | Q35103751 | ||
| Screening for VPS35 mutations in Parkinson's disease | Q36775809 | ||
| Study of the genetic variability in a Parkinson's Disease gene: EIF4G1 | Q37162224 | ||
| Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease | Q39601078 | ||
| Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population | Q43436466 | ||
| VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population | Q46295075 | ||
| Improved splice site detection in Genie | Q46338894 | ||
| Analysis of donor splice sites in different eukaryotic organisms | Q52261602 | ||
| Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group | Q57273925 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 982-989 | |
| P577 | publication date | 2013-02-13 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease | |
| P478 | volume | 80 |
| Q92586724 | Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician |
| Q57178432 | Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects |
| Q38121773 | Advances in the genetics of Parkinson disease |
| Q34658348 | Application of next-generation sequencing technologies in Neurology |
| Q55058366 | Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? |
| Q64876559 | Association analysis of EIF4G1 and Parkinson disease in Xinjiang Uygur and Han nationality |
| Q40279223 | Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein |
| Q38985873 | Cutaneous malignant melanoma and Parkinson disease: Common pathways? |
| Q37053959 | Decoding Parkinson's Disease Pathogenesis: The Role of Deregulated mRNA Translation |
| Q33665756 | EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population |
| Q48256432 | EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts |
| Q47320399 | Epigenetics in Parkinson's Disease |
| Q38233866 | Genetics and genomics of Parkinson's disease |
| Q28077356 | Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance |
| Q34550197 | Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways |
| Q64248689 | Golgi Complex Dynamics and Its Implication in Prevalent Neurological Disorders |
| Q28115600 | Identification of TMEM230 mutations in familial Parkinson's disease |
| Q35557260 | Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein. |
| Q64069696 | Integrated Analysis of Whole Exome Sequencing and Copy Number Evaluation in Parkinson's Disease |
| Q38253871 | LRRK2 pathobiology in Parkinson's disease |
| Q61801081 | Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease |
| Q39031304 | Rabs, Membrane Dynamics, and Parkinson's Disease |
| Q54709457 | Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls. |
| Q38116806 | Recent advances in Parkinson’s disease genetics. |
| Q88654489 | Retromer Dysfunction and Neurodegenerative Disease |
| Q24294458 | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease |
| Q37663839 | Role of translation initiation factor 4G in lifespan regulation and age-related health |
| Q28116373 | The EIF4G1 gene and Parkinson's disease |
| Q39235096 | The emerging role of retromer in neuroprotection |
| Q47324789 | The functional roles of retromer in Parkinson's disease |
| Q34336776 | The pallidopyramidal syndromes: nosology, aetiology and pathogenesis |
| Q35186622 | The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review |
| Q42065653 | Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2). |
| Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
| Q37098159 | Whole-Exome Sequencing in Familial Parkinson Disease |
Search more.